AAAAAA
Results: 26-38/38
Authors:
Shanahan, EM
Sheahan, K
McDonald, K
Bresnihan, B
Citation: Em. Shanahan et al., Dilated cardiomyopathy in Wegener's granulomatosis, RHEUMATOLOG, 38(11), 1999, pp. 1164-1166
Authors:
Cunnane, G
FitzGerald, O
Hummel, KM
Gay, RE
Gay, S
Bresnihan, B
Citation: G. Cunnane et al., Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis, RHEUMATOLOG, 38(1), 1999, pp. 34-42
Authors:
Kane, D
Greaney, T
Bresnihan, B
Gibney, R
Fitzgerald, O
Citation: D. Kane et al., Ultrasonography in the diagnosis and management of psoriatic dactylitis, J RHEUMATOL, 26(8), 1999, pp. 1746-1751
Authors:
Costello, P
Bresnihan, B
O'Farrelly, C
Fitzgerald, O
Citation: P. Costello et al., Predominance of CD8+ T lymphocytes in psoriatic arthritis, J RHEUMATOL, 26(5), 1999, pp. 1117-1124
Authors:
Bresnihan, B
Citation: B. Bresnihan, Pathogenesis of joint damage in rheumatoid arthritis, J RHEUMATOL, 26(3), 1999, pp. 717-719
Authors:
Molenaar, ETH
Boers, M
van der Heijde, DMFM
Alarcon, G
Bresnihan, B
Cardiel, M
Edmonds, J
Felson, D
Furst, DE
Kirwan, J
Lassere, M
Paulus, H
Rau, R
van Riel, PLCM
Scott, D
Simon, L
Strand, V
Citation: Eth. Molenaar et al., Imaging in rheumatoid arthritis: Results of group discussions, J RHEUMATOL, 26(3), 1999, pp. 749-751
Authors:
Youssef, P
Roth, J
Frosch, M
Costello, P
Fitzgerald, O
Sorg, C
Bresnihan, B
Citation: P. Youssef et al., Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane, J RHEUMATOL, 26(12), 1999, pp. 2523-2528
Authors:
Bresnihan, B
Alvaro-Gracia, JM
Cobby, M
Doherty, M
Domljan, Z
Emery, P
Nuki, G
Pavelka, K
Rau, R
Rozman, B
Watt, I
Williams, B
Aitchison, R
McCabe, D
Musikic, P
Citation: B. Bresnihan et al., Blindedness in clinical trials of therapies for rheumatoid arthritis: comment on the article by Bresnihan et al - Reply, ARTH RHEUM, 42(8), 1999, pp. 1782-1782
Authors:
Bresnihan, B
Citation: B. Bresnihan, Blindedness in clinical trials of therapies for rheumatoid arthritis: Comment on article by Bresnihan et al - Reply (vol 42, pg 1782, 1999), ARTH RHEUM, 42(10), 1999, pp. 2238-2238
Authors:
Cunnane, G
Bjork, L
Ulfgren, AK
Lindblad, S
FitzGerald, O
Bresnihan, B
Andersson, U
Citation: G. Cunnane et al., Quantitative analysis of synovial membrane inflammation: a comparison between automated and conventional microscopic measurements, ANN RHEUM D, 58(8), 1999, pp. 493-499
Authors:
Bresnihan, B
Citation: B. Bresnihan, Treatment of rheumatoid arthritis with interleukin 1 receptor antagonist, ANN RHEUM D, 58, 1999, pp. 96-98
Authors:
Noone, PG
Bresnihan, B
Citation: Pg. Noone et B. Bresnihan, Rheumatic disease in cystic fibrosis, CYSTIC FIBROSIS IN ADULTS, 1999, pp. 439-447
Authors:
Bresnihan, B
Alvaro-Gracia, JM
Cobby, M
Doherty, M
Domljan, Z
Emery, P
Nuki, G
Pavelka, K
Rau, R
Rozman, B
Watt, I
Williams, B
Aitchison, R
McCabe, D
Musikic, P
Citation: B. Bresnihan et al., Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist, ARTH RHEUM, 41(12), 1998, pp. 2196-2204